Optiver Holding
LABD icon

Optiver Holding’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Optiver Holding’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-166
Closed -$12K – 1476
2024
Q4 		$12K Buy
+166
New +$10.2K ﹤0.01% 736
2022
Q2 		– Sell
-56
Closed -$20K – 465
2022
Q1 		$20K Sell
56
-20
-26% -$7.84K ﹤0.01% 379
2021
Q4 		$16K Hold
76
– – ﹤0.01% 623
2021
Q3 		$16K Sell
76
-176
-70% -$37.4K ﹤0.01% 499
2021
Q2 		$49K Buy
+252
New +$56.5K ﹤0.01% 285

Other funds holding LABD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
HT
Headlands Technologies Chicago, Illinois $878M AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Optiver Holding's LABD Position: Q1 2025 in Review

Optiver Holding sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q1 2025, closing a stake of 166 shares — an estimated $12K sold.

Optiver Holding first reported a position in LABD in Q2 2021 and held it in 5 quarters. The position peaked at $49K in Q2 2021. 14 funds tracked by Wall St. Rank hold LABD as of Q1 2025.

  • Optiver Holding reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q1 2025 after selling out during the quarter.
  • Optiver Holding sold 166 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2025, an estimated $12K.
  • Optiver Holding first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2021 and held it in 5 quarters.
  • Optiver Holding's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $49K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2025.

Based on Optiver Holding's 13F filing for Q1 2025, filed 15 May 2025.